Company intelligence / Profile preview

Labospace

Ownership: Private
Development stage: Other

Overview

Labospace is an ISO-certified contract research organization and laboratory service provider specializing in biomarker assays, antibody validation, quantitative pathogen detection, gene editing support, and next-generation sequencing. It serves pharma, biotech companies, academia, and hospitals with custom solutions using advanced technologies such as Luminex/Multiplex platforms and NGS. The company operates from Milan with additional hubs in San Diego and Oxford.

Modalities: AntibodyMultiplex PCR assayNext-generation sequencing (NGS)Gene editing (CRISPR/Cas9)
Industry: Contract Research Organization

Partnerships

FineTest ELISA Kit manufacturer/distributor partnershipPivotal Scientific Ltd. for business development/B2B partnerships

Beyond the preview

Go deeper on Labospace.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Labospace.

Explore the full profile